Navigation Links
Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
Date:8/19/2007

RESEARCH TRIANGLE PARK, N.C., Aug. 15 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Michael Troullis as its Chief Financial Officer, effective immediately. Troullis had been acting CFO since former CFO John Ratliff was appointed Quintiles' Chief Operating Officer last year.

Troullis joined Quintiles in 1992 as Director of Finance, Europe. Prior to his appointment as acting CFO, Troullis was Senior Vice President and Worldwide Controller.

"Mike's financial expertise and deep knowledge of Quintiles and our markets make him the best person to be the fourth CFO in Quintiles' 25-year history," said Dennis Gillings, CBE, Chairman and Chief Executive Officer of Quintiles Transnational. "He has helped put in place the financial systems and controls needed to support Quintiles' growth from a small CRO to being the global leader in helping companies bring medicines to market faster and more efficiently."

Troullis, who will report to Gillings, has a bachelor's degree in Economics from the University of Exeter (England) and is qualified as a United Kingdom Chartered Accountant.

Prior to joining Quintiles, Troullis had a 10-year career with CooperVision, where he held several positions of increasing responsibility, finally as European Finance Director; and six years with KPMG in the United Kingdom.

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.qtrn.com


'/>"/>
SOURCE Quintiles Transnational Corp.

Copyright©2007 PR Newswire.

Page: 1

Related biology technology :

1. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
2. Michael Rosencrance deals with medical overload through human-centric IT
3. Michael J. Fox coming to UW Waisman Center
4. VanderSanden appointed president of AT&T Wisconsin
5. State technology chief endorses IT audit recommendations
6. Fusion 2007: CA chief says IT complexity raises risk
7. Web-Based Learning Developed under new Chief Education Officer
8. Merge files financial reports by market opening
9. Merge fails to file quarterly financial report
10. Financial executives to launch Madison chapter
11. Third Wave Reports Third-Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 BioTech News ... patents and results of studies and trials.  Companies in ... Company (NYSE: LLY ), Gilead Sciences Inc. ... CELG ) and Arena Pharmaceuticals Inc. (NASDAQ: ARNA) ... developing prodrug therapeutics for the treatment of cancer, announced ...
(Date:9/19/2014)... ROCKLAND, Massachusetts , September 19, 2014 ... with the 53rd European Society for Paediatric Endocrinology (ESPE) ... advancement of science and medical research in the field ... of Merck KGaA, Darmstadt, Germany , ... Growth Innovation (GGI) for 2014. The awards were announced ...
(Date:9/18/2014)... 2014 About POCT ... a clinical laboratory. It helps in making fast ... and medication. POCT is gaining popularity due to ... such as diabetes, heart disease, and obesity. It ... standardized to minimize errors during the diagnosis of ...
(Date:9/18/2014)... , September 18, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced ... Materials - Global Strategic Business Report" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report analyzes the ... US$ Million by the following Product ...
Breaking Biology Technology:Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3
... have found a defense against the Black Plague, a disease ... Middle Ages and which government agencies perceive as a terrorist ... team have developed a vaccine that early research shows is ... of Health and USDA funded research appear in the August ...
... COLLEGE STATION, Sept. 24, 2008 America,s war on ... agents, and Texas A&M University chemist Dr. Frank Raushel ... that might neutralize one such chemical agent, the organophosphates. ... the 1930s but soon made their way into the ...
... (Nasdaq: SVNT ) today announced that Christopher,Clement, President ... corporate update at the upcoming Lazard Capital Markets 5th,Annual ... on Tuesday, November 18, 2008 at,9:25 a.m. ET. The ... in New,York City November 18-19, 2008., Individuals can ...
Cached Biology Technology:UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3Researcher working on destruction of chemical weapons 2Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th 2
(Date:9/21/2014)... are set to rise again in 2014 - reaching a ... cent projected rise in burning fossil fuels is revealed by ... by researchers at the Tyndall Centre for Climate Change Research ... Engineering, Mathematics and Physical Sciences at the University of Exeter. ... where world leaders will seek to catalyse action on climate ...
(Date:9/21/2014)... strains of bacteria have emerged that resist even the ... forms of tuberculosis and staphylococcus, infect more than 2 ... the urgent need for new treatments, scientists have discovered ... decade. , MIT engineers have now turned a powerful ... that can disable any target gene, they have shown ...
(Date:9/21/2014)... mussels and barnacles secrete very sticky proteins that help ... Inspired by these natural adhesives, a team of MIT ... to repair ships or help heal wounds and surgical ... MIT researchers engineered bacteria to produce a hybrid material ... a bacterial protein found in biofilms slimy layers ...
Breaking Biology News(10 mins):CO2 emissions set to reach new 40 billion ton record high in 2014 2CO2 emissions set to reach new 40 billion ton record high in 2014 3Battling superbugs 2Battling superbugs 3Battling superbugs 4Engineered proteins stick like glue -- even in water 2Engineered proteins stick like glue -- even in water 3
... (Boston) Boston University School of Medicine (BUSM) ... physiology, with joint appointments in biomedical engineering and medicine, ... Lipids. This award is being bestowed by ... in the application of nuclear magnetic resonance methods to ...
... This release is available in Spanish . ... (ARS) scientists are helping to increase understanding about the ... with potent antioxidant properties, in oat grain. Avns ... their many health benefits. The specific purpose of Avns ...
... , AUGUSTA, Ga. In a first-of-its-kind study, ... simulation driving can reduce Parkinson,s patients, threefold increased ... disease are three times more likely to have ... cognitive, motor and visuospatial impairments. Previous ...
Cached Biology News:Studies provide insight into key oat chemical 2Simulation study may help Parkinson's patients retain driving skills 2
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
Goat polyclonal to Lipocalin 2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
... immunoblotting the antibody reacts against the reduced ... MMP-2 or MMP-2 bound to TIMP-2. affinity ... Solution in 0.01 M phosphate buffered ... 15 mM sodium azide. synthetic peptide corresponding ...
Biology Products: